trimethoxy(2-trimethoxysilylethyl)silane

We are trimethoxy(2-trimethoxysilylethyl)silane CAS:18406-41-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Chemical Name:trimethoxy(2-trimethoxysilylethyl)silane
CAS.NO:18406-41-2
Synonyms:Ethylenebis(trimethoxysilane); hexa-Si-methoxy-Si,Si'-ethane-1,2-diyl-bis-silane; 1,2-Ethylenebis(trimethoxysilane); 2,7-Dioxa-3,6-disilaoctane,3,3,6,6-tetramethoxy;
Molecular Formula:C8H22O6Si2
Molecular Weight:270.42800
 
Physical and Chemical Properties:
Density:1.073;
Boiling point:103-104^oC;
Flash point:109^oC;
Index of Refraction:1.409;
 
Specification:
Appearance:Clear to straw liquid
Purity(GC):≥95.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It can be used to improve the adhesion of RTV silicone sealants to dry or wet surface, and improve its weather resistance.
It can be used to formulate chromate-free, water-borne primers to protect metals from corrosion.




Related News: The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.1-(Dimethylamino)-3-(2-(3-methoxyphenethyl)phenoxy)propan-2-ol hydrochloride CAS:135261-74-4 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.cis-3-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-2,2-dimethylcyclopropanecarboxylic acid CAS:72748-35-7 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.181289-33-8 Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.